Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term endocrine therapy. Found 9 abstracts

Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer. Annals of Surgical Oncology. 2012 May;19(5):1508-16.   PMCID: not NIH funded
Carlson RW, Allred C, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. Invasive Breast Cancer. Journal of the National Comprehensive Cancer Network. 2011 Feb;9(2):136-222.   PMCID: not NIH funded - practice guideline
Hu ZZ, Kagan BL, Ariazi EA, Rosenthal DS, Zhang LH, Li JV, Huang HZ, Wu C, Jordan VC, Riegel AT, Wellstein A. Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells. PLoS One. 2011 Jun;6(6):e20410.   PMCID: PMC3124472
Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Som G, Topham NS, Ward JH, Winer EP, Wolff AC. Breast Cancer: Noninvasive and Special Situations. Journal of the National Comprehensive Cancer Network. 2010 Oct;8(10):1182-207.   PMCID: not NIH funded
Abdel-Wahab M, Berkey BA, Krishan A, O'Brien T, Hammond E, Roach M, Lawton C, Pilepich M, Markoe A, Pollack A. Influence of number of CAG repeats on local control in the RTOG 86-10 protocol. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Feb;29(1):14-20.
O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice. CLINICAL CANCER RESEARCH. 2006 Jan;12(7):2255-63.
Jordan VC, Lewis JS, Osipo C, Cheng D. The apoptotic action of estrogen following exhaustive antihormonal therapy: A new clinical treatment strategy. Breast. 2005 Dec;14(6):624-30.
Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 2004 Jan;9 (6):606-16.
Mgbonyebi OP, Russo J, Russo IH. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Research. 1999 Apr 15;59(8):1903-10.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term endocrine therapy

endocrine therapy breast cancer surgical adjuvant breast randomized-trial breast-conserving therapy lobular carcinoma in situ NCCN Guidelines tamoxifen antihormonal therapy Oncology growth-factor receptor tamoxifen resistance mastectomy postmenopausal women radiation therapy adjuvant therapy NCCN Clinical Practice Guidelines randomized controlled-trial trial quality-of-life advanced breast-cancer ductal plasminogen-activator sentinel-node biopsy bowel project p-1 transgenic extracellular-matrix mice androgen lymph-node biopsy recommendations carcinoma-in-situ local recurrence index estrogen receptor activation lymph-node metastases cells c-erbb-2 expression chemotherapy raloxifene cyclin-dependent kinases therapy men receptor epithelial- nuclear receptor coactivator phase-iii skin-sparing mastectomy college athymic mice american-joint-committee prostate-cancer risk placebo-controlled trial tumors tyrosine length human breast-tumors aib1 phyllodes polymorphic cag rat uterus apoptosis src-3 united-states cancer androgen-receptor gene expression focal adhesion kinase cyclophosphamide chemotherapy resistant mcf-7 cells s-phase fraction kinase breast randomized-trials noninvasive breast predictive factors surgical adjuvant tumor-cells actin stress nuys prognostic phase-iii trial expert panel pagets-disease guideline ductal carcinoma in situ median follow-up predicting response inhibition activator inhibitor type-1 estrogen-receptor flow-cytometric analysis vitamin-d-receptor preoperative chemotherapy mammary-gland pathological complete response prostate cancer radiation tumor-growth prognostic factors growth-factors fibers in-situ hybridization monoclonal-antibody phosphorylation clinical-oncology first-line therapy carcinoma in situ serum-cholesterol 474 tamoxifen ici 46
Last updated on Thursday, April 02, 2020